About
Our mission: design, discover and deliver new medicines
More than 80 percent of validated therapeutic targets are intracellular. Drugging these targets is complicated by the significant barriers to intracellular delivery, including cell membranes and degradative systems, which have largely confined existing intracellular therapies to small molecule drugs.